Dr. Reddy's Laboratories has announced the launch of Toripalimab in India. This drug is designed to treat adults suffering ...
Nasopharyngeal carcinoma (NPC) is a rare, aggressive form of head and neck cancer that originates in the nasopharynx, the ...
Dr. Reddy's Laboratories launched Zytorvi (Toripalimab), a novel immunotherapy drug for recurrent or metastatic nasopharyngeal carcinoma (NPC), a rare head and neck cancer. This marks India as the ...
As whooping cough cases rise in the U.S., a new nasal vaccine developed by Tulane University may hold the key to reducing the ...
As whooping cough cases rise in the U.S., a new nasal vaccine developed by Tulane University may hold the key to reducing the spread of the highly ...
Dr. Reddy's Laboratories on Thursday announced the launch of Toripalimab in India to treat adults with Nasopharyngeal ...